BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 12931324)

  • 1. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
    Kinahan PE; Hasegawa BH; Beyer T
    Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.
    Visvikis D; Costa DC; Croasdale I; Lonn AH; Bomanji J; Gacinovic S; Ell PJ
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):344-53. PubMed ID: 12634961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.
    Nehmeh SA; Erdi YE; Kalaigian H; Kolbert KS; Pan T; Yeung H; Squire O; Sinha A; Larson SM; Humm JL
    J Nucl Med; 2003 Dec; 44(12):1940-4. PubMed ID: 14660720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
    Vogel WV; van Dalen JA; Schinagl DA; Kaanders JH; Huisman H; Corstens FH; Oyen WJ
    Nucl Med Commun; 2006 Jun; 27(6):515-9. PubMed ID: 16710106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
    Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
    J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition protocol considerations for combined PET/CT imaging.
    Beyer T; Antoch G; Müller S; Egelhof T; Freudenberg LS; Debatin J; Bockisch A
    J Nucl Med; 2004 Jan; 45 Suppl 1():25S-35S. PubMed ID: 14736833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT: artifacts caused by bowel motion.
    Nakamoto Y; Chin BB; Cohade C; Osman M; Tatsumi M; Wahl RL
    Nucl Med Commun; 2004 Mar; 25(3):221-5. PubMed ID: 15094438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT: panacea, redundancy, or something in between?
    Vogel WV; Oyen WJ; Barentsz JO; Kaanders JH; Corstens FH
    J Nucl Med; 2004 Jan; 45 Suppl 1():15S-24S. PubMed ID: 14736832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT: fundamental principles.
    Seemann MD
    Eur J Med Res; 2004 May; 9(5):241-6. PubMed ID: 15257877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography.
    Townsend DW
    Semin Nucl Med; 2008 May; 38(3):152-66. PubMed ID: 18396176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT scanners: a hardware approach to image fusion.
    Townsend DW; Beyer T; Blodgett TM
    Semin Nucl Med; 2003 Jul; 33(3):193-204. PubMed ID: 12931321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
    Beyer T; Antoch G; Bockisch A; Stattaus J
    J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT image navigation and communication.
    Ratib O
    J Nucl Med; 2004 Jan; 45 Suppl 1():46S-55S. PubMed ID: 14736835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
    Bar-Shalom R; Yefremov N; Guralnik L; Gaitini D; Frenkel A; Kuten A; Altman H; Keidar Z; Israel O
    J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
    Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
    J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT.
    Wahl RL
    J Nucl Med; 2004 Jan; 45 Suppl 1():82S-95S. PubMed ID: 14736839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
    Tsai CC; Tsai CS; Ng KK; Lai CH; Hsueh S; Kao PF; Chang TC; Hong JH; Yen TC
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1674-83. PubMed ID: 12937950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT: a new imaging technology in nuclear medicine.
    Schöder H; Erdi YE; Larson SM; Yeung HW
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1419-37. PubMed ID: 12961037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.